- Home
- TNON vs CYCN Comparison
TNON vs CYCN Comparison
Compare TNON & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- CYCN
- Stock Information
- Founded
- TNON 2012
- CYCN 2018
- Country
- TNON United States
- CYCN United States
- Employees
- TNON N/A
- CYCN N/A
- Industry
- TNON Medical Specialities
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- TNON Health Care
- CYCN Health Care
- Exchange
- TNON Nasdaq
- CYCN Nasdaq
- Market Cap
- TNON 6.9M
- CYCN 6.5M
- IPO Year
- TNON 2022
- CYCN N/A
- Fundamental
- Price
- TNON $1.00
- CYCN $3.18
- Analyst Decision
- TNON Strong Buy
- CYCN
- Analyst Count
- TNON 3
- CYCN 0
- Target Price
- TNON $11.67
- CYCN N/A
- AVG Volume (30 Days)
- TNON 257.6K
- CYCN 20.7K
- Earning Date
- TNON 05-13-2025
- CYCN 05-06-2025
- Dividend Yield
- TNON N/A
- CYCN N/A
- EPS Growth
- TNON N/A
- CYCN N/A
- EPS
- TNON N/A
- CYCN N/A
- Revenue
- TNON $3,284,000.00
- CYCN $2,081,000.00
- Revenue This Year
- TNON $46.26
- CYCN N/A
- Revenue Next Year
- TNON $58.02
- CYCN N/A
- P/E Ratio
- TNON N/A
- CYCN N/A
- Revenue Growth
- TNON 2.18
- CYCN N/A
- 52 Week Low
- TNON $0.91
- CYCN $1.27
- 52 Week High
- TNON $15.79
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- TNON 37.47
- CYCN 53.92
- Support Level
- TNON $0.98
- CYCN $3.04
- Resistance Level
- TNON $1.35
- CYCN $3.26
- Average True Range (ATR)
- TNON 0.05
- CYCN 0.25
- MACD
- TNON -0.00
- CYCN 0.01
- Stochastic Oscillator
- TNON 9.52
- CYCN 80.00
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.